Physiology, pharmacology, and therapeutic potential of protease-activated receptors in vascular disease

Pharmacology and Therapeutics

Volumn 134, Issue 2, 2012, Pages 246-259

  Lee, Hannah ^a   Hamilton, Justin R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Platelets; Protease activated receptor; Thrombin; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ATOPAXAR; BMS 200261; CLOPIDOGREL; G PROTEIN COUPLED RECEPTOR; PEPTIDOMIMETIC AGENT; PLACEBO; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; PROTEINASE ACTIVATED RECEPTOR ANTAGONIST; SCH 79797; THROMBIN; UNCLASSIFIED DRUG; VORAPAXAR; WARFARIN;

ACUTE CORONARY SYNDROME; AMINO ACID SEQUENCE; ANGIOGENESIS; ARTERY THROMBOSIS; BLEEDING; BLOOD VESSEL PERMEABILITY; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIUM CELL; HEART INFARCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, PROTEINASE-ACTIVATED; VASCULAR DISEASES;

EID: 84862812021     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.01.007     Document Type: Review

References (216)

1. H.S. Ahn, L. Arik, G. Boykow, D.A. Burnett, M.A. Caplen, and M. Czarniecki Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists Bioorg Med Chem Lett 9 1999 2073 2078 (Pubitemid 29336404)
2. H.S. Ahn, C. Foster, G. Boykow, A. Stamford, M. Manna, and M. Graziano Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1- methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist Biochem Pharmacol 60 2000 1425 1434
3. B. Al-Ani, M. Saifeddine, S.J. Wijesuriya, and M.D. Hollenberg Modified proteinase-activated receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin J Pharmacol Exp Ther 300 2002 702 708
4. A.G. Almonte, C.E. Hamill, J.P. Chhatwal, T.S. Wingo, J.A. Barber, and P.N. Lyuboslavsky Learning and memory deficits in mice lacking protease activated receptor-1 Neurobiol Learn Mem 88 2007 295 304 (Pubitemid 47321213)
5. M. Aman, M. Hirano, H. Kanaide, and K. Hirano Upregulation of proteinase-activated receptor-2 and increased response to trypsin in endothelial cells after exposure to oxidative stress in rat aortas J Vasc Res 47 2010 494 506
6. P. Andrade-Gordon, C.K. Derian, B.E. Maryanoff, H.C. Zhang, M.F. Addo, and W. Cheung Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats J Pharmacol Exp Ther 298 2001 34 42 (Pubitemid 32574507)
7. P. Andrade-Gordon, B.E. Maryanoff, C.K. Derian, H.C. Zhang, M.F. Addo, and A.L. Darrow Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor Proc Natl Acad Sci U S A 96 1999 12257 12262 (Pubitemid 29513488)
8. F. Andreotti, L. Testa, G.G. Biondi-Zoccai, and F. Crea Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients Eur Heart J 27 2006 519 526
9. M.J. Antonaccio, D. Normandin, R. Serafino, and S. Moreland Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle J Pharmacol Exp Ther 266 1993 125 132 (Pubitemid 23315637)
10. J.A. Barnes, S. Singh, and A.V. Gomes Protease activated receptors in cardiovascular function and disease Mol Cell Biochem 263 2004 227 239 (Pubitemid 39256161)
11. G.D. Barry, G.T. Le, and D.P. Fairlie Agonists and antagonists of protease activated receptors (PARs) Curr Med Chem 13 2006 243 265
12. K. Bartha, E. Domotor, F. Lanza, V. Adam-Vizi, and M. Machovich Identification of thrombin receptors in rat brain capillary endothelial cells J Cereb Blood Flow Metab 20 2000 175 182 (Pubitemid 30019843)
13. R.C. Becker Antithrombotic therapy after myocardial infarction N Engl J Med 347 2002 1019 1022
14. R.C. Becker, T.W. Meade, P.B. Berger, M. Ezekowitz, C.M. O'Connor, and D.A. Vorchheimer The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 776S 814S (Pubitemid 351894917)
15. R.C. Becker, D.J. Moliterno, L.K. Jennings, K.S. Pieper, J. Pei, and A. Niederman Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study Lancet 373 2009 919 928
16. R. Beri The use and identification of protease-activated receptor 3 (PAR-3) for the treatment of asthma WO2006054931 2006
17. J. Bernard, and J.P. Soulier Sur une nouvelle variete de dystrophie thrombocytairehemorragipare congenitale Sem Hop 24 1948 3217 3223
18. M.S. Bernatowicz, C.E. Klimas, K.S. Hartl, M. Peluso, N.J. Allegretto, and S.M. Seiler Development of potent thrombin receptor antagonist peptides J Med Chem 39 1996 4879 4887 (Pubitemid 26422501)
19. D.L. Bhatt, K.A. Fox, W. Hacke, P.B. Berger, H.R. Black, and W.E. Boden Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
20. B.D. Blackhart, K. Emilsson, D. Nguyen, W. Teng, A.J. Martelli, and S. Nystedt Ligand cross-reactivity within the protease-activated receptor family J Biol Chem 271 1996 16466 16471 (Pubitemid 26238996)
21. A. Bocquet, R. Letienne, S. Sablayrolles, L. De Vries, M. Perez, and B. Le Grand Effects of a new PAR1 antagonist, F 16618, on smooth muscle cell contraction Eur J Pharmacol 611 2009 60 63
22. S.K. Bohm, W. Kong, D. Bromme, S.P. Smeekens, D.C. Anderson, and A. Connolly Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2 Biochem J 314 Pt 3 1996 1009 1016 (Pubitemid 26097768)
23. S.K. Bohm, K. McConalogue, W. Kong, and N.W. Bunnett Proteinase-activated receptors: new functions for old enzymes News Physiol Sci 13 1998 231 240
24. F. Bono, I. Lamarche, and J.M. Herbert Induction of vascular smooth muscle cell growth by selective activation of the proteinase activated receptor-2 Biochem Biophys Res Commun 241 1997 762 764 (Pubitemid 28036731)
25. E. Bretschneider, R. Kaufmann, M. Braun, G. Nowak, E. Glusa, and K. Schror Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells Br J Pharmacol 132 2001 1441 1446 (Pubitemid 32281032)
26. E. Bretschneider, R. Spanbroek, K. Lotzer, A.J. Habenicht, and K. Schror Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells Thromb Haemost 90 2003 704 709 (Pubitemid 37287639)
27. E. Camerer, W. Huang, and S.R. Coughlin Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa Proc Natl Acad Sci U S A 97 2000 5255 5260 (Pubitemid 30313705)
28. Q. Capers IV, J.B. Laursen, T. Fukui, S. Rajagopalan, I. Mori, and P. Lou Vascular thrombin receptor regulation in hypertensive rats Circ Res 80 1997 838 844 (Pubitemid 27230058)
29. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
30. M.A. Ceruso, D.F. McComsey, G.C. Leo, P. Andrade-Gordon, M.F. Addo, and R.M. Scarborough Thrombin receptor-activating peptides (TRAPs): investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies Bioorg Med Chem 7 1999 2353 2371 (Pubitemid 30122737)
31. S. Chackalamannil, D. Doller, K. Eagen, M. Czarniecki, H.S. Ahn, and C.J. Foster Potent, low molecular weight thrombin receptor antagonists Bioorg Med Chem Lett 11 2001 2851 2853
32. D. Chen, A. Carpenter, J. Abrahams, R.C. Chambers, R.I. Lechler, and J.H. McVey Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo J Exp Med 205 2008 1739 1746
33. H.S. Chen, S.C. Kuo, C.M. Teng, F.Y. Lee, J.P. Wang, and Y.C. Lee Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl) benzoate (YD-3) derivatives Bioorg Med Chem 16 2008 1262 1278
34. W.-M. Cheung, P. Andrade-Gordon, C.K. Derian, and B.P. Damiano Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease-activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo Can J Physiol Pharmacol 76 1998 16 25 (Pubitemid 28201094)
35. W.-M. Cheung, M.R. D'Andrea, P. Andrade-Gordon, and B.P. Damiano Altered vascular injury responses in mice deficient in protease-activated receptor-1 Arterioscler Thromb Vasc Biol 19 1999 3014 3020
36. P. Chieng-Yane, A. Bocquet, R. Letienne, T. Bourbon, S. Sablayrolles, M. Perez, S. Hatem, A.M. Lompre, B. Le Grand, and M. David-Dufilho Protease activated Receptor-1 antagonist, F 16618 reduces arterial restenosis by down-regulation of TNF{alpha} and MMP7 expression, and migration and proliferation of vascular smooth muscle cells J Pharmacol Exp Ther. 336 2011 643 651
37. M. Chintala, J. Strony, B. Yang, S. Kurowski, and Q. Li SCH 602539, a protease-activated receptor-1 antagonist, inhibits thrombosis alone and in combination with cangrelor in a Folts model of arterial thrombosis in cynomolgus monkeys Arterioscler Thromb Vasc Biol 30 2010 2143 2149
38. S.W. Chung, J.W. Park, S.A. Lee, S.K. Eo, and K. Kim Thrombin promotes proinflammatory phenotype in human vascular smooth muscle cell Biochem Biophys Res Commun 396 2010 748 754
39. C. Cicala, A. Pinto, M. Bucci, R. Sorrentino, B. Walker, and P. Harriot Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo Circulation 99 1999 2590 2597 (Pubitemid 29228292)
40. G. Cirino, C. Cicala, M.R. Bucci, L. Sorrentino, J.M. Maraganore, and S.R. Stone Thrombin functions as an inflammatory mediator through activation of its receptor J Exp Med 183 1996 821 827
41. T.M. Cocks, and J.D. Moffatt Protease-activated receptors: sentries for inflammation? Trends Pharmacol Sci 21 2000 103 108 (Pubitemid 30114325)
42. B.S. Coller, P. Ward, M. Ceruso, L.E. Scudder, K. Springer, and J. Kutok Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M Biochemistry 31 1992 11713 11720
43. T.M. Connolly, C. Condra, D.M. Feng, J.J. Cook, M.T. Stranieri, and C.F. Reilly Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides Thromb Haemost 72 1994 627 633 (Pubitemid 24305662)
44. A.J. Connolly, H. Ishihara, M.L. Kahn, R.V. Farese Jr., and S.R. Coughlin Role of the thrombin receptor in development and evidence for a second receptor Nature 381 1996 516 519
45. J.J. Cook, G.R. Sitko, B. Bednar, C. Condra, M.J. Mellott, and D.M. Feng An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey Circulation 91 1995 2961 2971
46. C.U. Corvera, O. Dery, K. McConalogue, S.K. Bohm, L.M. Khitin, and G.H. Caughey Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2 J Clin Invest 100 1997 1383 1393 (Pubitemid 27425762)
47. C.U. Corvera, O. Dery, K. McConalogue, P. Gamp, M. Thoma, and B. Al-Ani Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2 J Physiol 517 1999 741 756 (Pubitemid 29306461)
48. S.R. Coughlin Thrombin signalling and protease-activated receptors Nature 407 2000 258 264
49. S.R. Coughlin Protease-activated receptors in hemostasis, thrombosis and vascular biology J Thromb Haemost 3 2005 1800 1814 (Pubitemid 41716567)
50. L. Covic, A.L. Gresser, J. Talavera, S. Swift, and A. Kuliopulos Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides Proc Natl Acad Sci U S A 99 2002 643 648 (Pubitemid 34106565)
51. L. Covic, M. Misra, J. Badar, C. Singh, and A. Kuliopulos Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation Nat Med 8 2002 1161 1165 (Pubitemid 35175972)
52. L.D. Cupit, V.A. Schmidt, and W.F. Bahou Proteolytically activated receptor-3: a member of an emerging gene family of protease-activated receptors expressed on vascular endothelial cells and platelets Trends Cardiovasc Med 9 1999 42 48 (Pubitemid 29142579)
53. K. Dabbagh, G.J. Laurent, R.J. McAnulty, and R.C. Chambers Thrombin stimulates smooth muscle cell procollagen synthesis and mRNA levels via a PAR-1 mediated mechanism Thromb Haemost 79 1998 405 409 (Pubitemid 28065893)
54. B.P. Damiano, M.R. D'Andrea, L. de Garavilla, W.-M. Cheung, and P. Andrade-Gordon Increased expression of protease-activated receptor-2 (PAR-2) in balloon-injured rat carotid artery Thromb Haemost 81 1999 808 814 (Pubitemid 29216570)
55. M.R. D'Andrea, C.K. Derian, D. Leturcq, S.M. Baker, A. Brunmark, and P. Ling Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues J Histochem Cytochem 46 1998 157 164 (Pubitemid 28087846)
56. S. Dangwal, B.H. Rauch, T. Gensch, L. Dai, E. Bretschneider, and C.F. Vogelaar High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cells Arterioscler Thromb Vasc Biol 31 2011 624 633
57. T. David, P. Ohlmann, A. Eckly, S. Moog, J.P. Cazenave, and C. Gachet Inhibition of adhesive and signaling functions of the platelet GPIb-V-IX complex by a cell penetrating GPIbalpha peptide J Thromb Haemost 4 2006 2645 2655 (Pubitemid 44741561)
58. E. De Candia, S.W. Hall, S. Rutella, R. Landolfi, R.K. Andrews, and R. De Cristofaro Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets J Biol Chem 276 2001 4692 4698
59. L. de Garavilla, N. Vergnolle, S.H. Young, H. Ennes, M. Steinhoff, and V.S. Ossovskaya Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism Br J Pharmacol 133 2001 975 987 (Pubitemid 32762406)
60. C.K. Derian, B.P. Damiano, M.F. Addo, A.L. Darrow, M.R. D'Andrea, and M. Nedelman Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates J Pharmacol Exp Ther 304 2003 855 861 (Pubitemid 36152366)
61. C.K. Derian, B.P. Damiano, M.F. Addo, A.L. Darrow, M.R. D'Andrea, and M. Nedelman Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates J Pharmacol Exp Ther 304 2003 855 861 (Pubitemid 36152366)
62. C.K. Derian, B.E. Maryanoff, P. Andrade-Gordon, and H.-C. Zhang Design and evaluation of potent peptide-mimetic PAR1 antagonists Drug Dev Res 59 2003 355 366 (Pubitemid 37102186)
63. O. Dery, C.U. Corvera, M. Steinhoff, and N.W. Bunnett Proteinase-activated receptors: novel mechanisms of signaling by serine proteases Am J Physiol Cell Physiol 274 1998 C1429 C1452
64. K. Emilsson, C. Wahlstedt, M.-K. Sun, S. Nystedt, C. Owman, and J. Sundelin Vascular effects of proteinase-activated receptor 2 agonist peptide J Vasc Res 34 1997 267 272 (Pubitemid 27292646)
65. T.R. Faruqi, E.J. Weiss, M.J. Shapiro, W. Huang, and S.R. Coughlin Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function J Biol Chem 275 2000 19728 19734 (Pubitemid 30441571)
66. W.R. Ferrell, J.C. Lockhart, E.B. Kelso, L. Dunning, R. Plevin, and S.E. Meek Essential role for proteinase-activated receptor-2 in arthritis J Clin Invest 111 2003 35 41 (Pubitemid 36134846)
67. L.D. Fiore, M.D. Ezekowitz, M.T. Brophy, D. Lu, J. Sacco, and P. Peduzzi Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study Circulation 105 2002 557 563 (Pubitemid 34123428)
68. M.T. Fox, P. Harriott, B. Walker, and S.R. Stone Identification of potential activators of proteinase-activated receptor-2 FEBS Lett 417 1997 267 269 (Pubitemid 27511601)
69. J. Fu, A.P. Naren, X. Gao, G.U. Ahmmed, and A.B. Malik Protease-activated receptor-1 activation of endothelial cells induces protein kinase Calpha-dependent phosphorylation of syntaxin 4 and Munc18c: role in signaling p-selectin expression J Biol Chem 280 2005 3178 3184 (Pubitemid 40223779)
70. R. Gallo, A. Padurean, V. Toschi, J. Bichler, J.T. Fallon, and J.H. Chesebro Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries Circulation 97 1998 581 588 (Pubitemid 28090688)
71. E. Gandossi, C. Lunven, and C.N. Berry Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro Br J Pharmacol 129 2000 1021 1027 (Pubitemid 30142917)
72. 2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet-derived growth factor messenger RNA expression in cultured endothelium J Cell Physiol 156 1993 541 549 (Pubitemid 23269871)
73. A.G. Gilman G proteins: transducers of receptor-generated signals Annu Rev Biochem 56 1987 615 649
74. S. Goto, H. Ogawa, M. Takeuchi, M.D. Flather, and D.L. Bhatt Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease Eur Heart J 31 2010 2601 2613
75. R.J. Grand, A.S. Turnell, and P.W. Grabham Cellular consequences of thrombin-receptor activation Biochem J 313 Pt 2 1996 353 368 (Pubitemid 26030120)
76. K.K. Griendling, and R.W. Alexander Endothelial control of the cardiovascular system: recent advances FASEB J 10 1996 283 292 (Pubitemid 26079947)
77. C.T. Griffin, Y. Srinivasan, Y.W. Zheng, W. Huang, and S.R. Coughlin A role for thrombin receptor signaling in endothelial cells during embryonic development Science 293 2001 1666 1670 (Pubitemid 32807847)
78. I.J. Gudmundsdottir, N.N. Lang, N.A. Boon, C.A. Ludlam, D.J. Webb, and K.A. Fox Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans J Am Coll Cardiol 51 2008 1749 1756 (Pubitemid 351621987)
79. I.J. Gudmundsdottir, I.L. Megson, J.S. Kell, C.A. Ludlam, K.A. Fox, and D.J. Webb Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans Circulation 114 2006 1625 1632 (Pubitemid 44547433)
80. P.A. Gurbel, K.P. Bliden, B.L. Hiatt, and C.M. O'Connor Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913 (Pubitemid 36736631)
81. J.R. Hamilton Protease-activated receptors as targets for antiplatelet therapy Blood Rev 23 2009 61 65
82. J.R. Hamilton, J.M. Chow, and T.M. Cocks Protease-activated receptor-2 turnover stimulated independently of receptor activation in porcine coronary endothelial cells Br J Pharmacol 127 1999 617 622 (Pubitemid 29276646)
83. J.R. Hamilton, and T.M. Cocks Heterogeneous mechanisms of endothelium-dependent relaxation to thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary artery Br J Pharmacol 130 2000 181 188 (Pubitemid 30248443)
84. J.R. Hamilton, I. Cornelissen, and S.R. Coughlin Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets J Thromb Haemost 2 2004 1429 1435 (Pubitemid 40186142)
85. J.R. Hamilton, A.G. Frauman, and T.M. Cocks Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists Circ Res 89 2001 92 98 (Pubitemid 34135497)
86. J.R. Hamilton, J.D. Moffatt, A.G. Frauman, and T.M. Cocks Protease-activated receptor 1 (PAR1) but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries J Cardiovasc Pharmacol 38 2001 108 119 (Pubitemid 32634995)
87. J.R. Hamilton, J.D. Moffatt, J. Tatoulis, and T.M. Cocks Enzymatic activation of endothelial protease-activated receptors is dependent on artery diameter in human and porcine isolated coronary arteries Br J Pharmacol 136 2002 492 501 (Pubitemid 34717693)
88. J.R. Hamilton, P.B. Nguyen, and T.M. Cocks Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries Circ Res 82 1998 1306 1312
89. K.K. Hansen, M. Saifeddine, and M.D. Hollenberg Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells Immunology 112 2004 183 190 (Pubitemid 38703564)
90. M.W.C. Hatton, S.L. Moar, and M. Richardson Deendothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface: correlation of uptake of fibrinogen and antithrombin III with thrombin generation by the exposed endothelium Am J Pathol 135 1989 499 508 (Pubitemid 19246208)
91. U. Heinelt, V. Wehner, M. Herrmann, K. Schoenafinger, H. Steinhagen, and B. Scheiper Preparation of triazolopyridazines as proteinase activated receptor (PAR-1) antagonists WO2009097970 2009
92. W.J. Hoekstra, B.L. Hulshizer, D.F. McComsey, P. Andrade-Gordon, J.A. Kauffman, and M.F. Addo Thrombin receptor (PAR-1) antagonists. Heterocycle-based peptidomimetics of the SFLLR agonist motif Bioorg Med Chem Lett 8 1998 1649 1654 (Pubitemid 28341603)
93. M.D. Hollenberg, A.A. Laniyonu, M. Saifeddine, and G.J. Moore Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypes Mol Pharmacol 43 1993 921 930 (Pubitemid 23178869)
94. M.D. Hollenberg, and M. Saifeddine Proteinase-activated receptor 4 (PAR4): activation and inhibition of rat platelet aggregation by PAR4-derived peptides Can J Physiol Pharmacol 79 2001 439 442 (Pubitemid 32747883)
95. M.D. Hollenberg, M. Saifeddine, and B. Al-Ani Proteinase-activated receptor-2 in rat aorta: structural requirements for agonist activity of receptor-activating peptides Mol Pharmacol 49 1996 229 233 (Pubitemid 26066108)
96. M.D. Hollenberg, M. Saifeddine, B. Al-Ani, and Y. Gui Proteinase-activated receptor 4 (PAR4): action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2 Can J Physiol Pharmacol 77 1999 458 464 (Pubitemid 30339575)
97. M.D. Hollenberg, M. Saifeddine, B. al-Ani, and A. Kawabata Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides Can J Physiol Pharmacol 75 1997 832 841 (Pubitemid 27451801)
98. M.D. Hollenberg, M. Saifeddine, S. Sandhu, S. Houle, and N. Vergnolle Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo Br J Pharmacol 143 2004 443 454 (Pubitemid 39452212)
99. L.J. Huang, M.L. Shih, H.S. Chen, S.L. Pan, C.M. Teng, and F.Y. Lee Synthesis of N2-(substituted benzyl)-3-(4-methylphenyl)indazoles as novel anti-angiogenic agents Bioorg Med Chem 14 2006 528 536
100. M. Hurlen, M. Abdelnoor, P. Smith, J. Erikssen, and H. Arnesen Warfarin, aspirin, or both after myocardial infarction N Engl J Med 347 2002 969 974
101. J.J. Hwa, L. Ghibaudi, P. Williams, M. Chintala, R. Zhang, and M. Chatterjee Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells Circ Res 78 1996 581 588 (Pubitemid 26106873)
102. H. Ishihara, A.J. Connolly, D. Zeng, M.L. Kahn, Y.W. Zheng, and C. Timmons Protease-activated receptor 3 is a second thrombin receptor in humans Nature 386 1997 502 506 (Pubitemid 27164077)
103. J.E. Italiano Jr., J.L. Richardson, S. Patel-Hett, E. Battinelli, A. Zaslavsky, and S. Short Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released Blood 111 2008 1227 1233 (Pubitemid 351213404)
104. M.E. Ivey, and P.J. Little Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways Thromb Res 123 2008 288 297
105. K. Johnson, Y. Choi, E. DeGroot, I. Samuels, A. Creasey, and L. Aarden Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation J Immunol 160 1998 5130 5135 (Pubitemid 28215352)
106. M.L. Kahn, S.R. Hammes, C. Botka, and S.R. Coughlin Gene and locus structure and chromosomal localization of the protease-activated receptor gene family J Biol Chem 273 1998 23290 23296 (Pubitemid 28417515)
107. M.L. Kahn, M. Nakanishi-Matsui, M.J. Shapiro, H. Ishihara, and S.R. Coughlin Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin J Clin Invest 103 1999 879 887 (Pubitemid 29152634)
108. M.L. Kahn, Y.W. Zheng, W. Huang, V. Bigornia, D. Zeng, and S. Moff A dual thrombin receptor system for platelet activation Nature 394 1998 690 694 (Pubitemid 28389797)
109. Y. Kai, K. Hirano, Y. Maeda, J. Nishimura, T. Sasaki, and H. Kanaide Prevention of the hypercontractile response to thrombin by proteinase-activated receptor-1 antagonist in subarachnoid hemorrhage Stroke 38 2007 3259 3265 (Pubitemid 350175746)
110. H. Kataoka, J.R. Hamilton, D.D. McKemy, E. Camerer, Y.W. Zheng, and A. Cheng Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells Blood 102 2003 3224 3231 (Pubitemid 37314759)
111. Y. Kato, Y. Kita, Y. Hirasawa-Taniyama, M. Nishio, K. Mihara, and K. Ito Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig Eur J Pharmacol 473 2003 163 169 (Pubitemid 36929880)
112. Y. Kato, Y. Kita, M. Nishio, Y. Hirasawa, K. Ito, and T. Yamanaka In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist Eur J Pharmacol 384 1999 197 202 (Pubitemid 30006956)
113. R. Kaufmann, B. Schulze, G. Krause, L.M. Mayr, U. Settmacher, and P. Henklein Proteinase-activated receptors (PARs)-the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1 Regul Pept 125 2005 61 66 (Pubitemid 39593709)
114. A. Kawabata, T. Kanke, D. Yonezawa, T. Ishiki, M. Saka, and M. Kabeya Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo J Pharmacol Exp Ther 309 2004 1098 1107 (Pubitemid 38669697)
115. A. Kawabata, R. Kuroda, T. Minami, K. Kataoka, and M. Taneda Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw Br J Pharmacol 125 1998 419 422 (Pubitemid 28451476)
116. E.B. Kelso, J.C. Lockhart, T. Hembrough, L. Dunning, R. Plevin, and M.D. Hollenberg Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation J Pharmacol Exp Ther 316 2006 1017 1024 (Pubitemid 43345273)
117. T.A. Khan, C. Bianchi, P. Voisine, J. Sandmeyer, J. Feng, and F.W. Sellke Aprotinin inhibits protease-dependent platelet aggregation and thrombosis Ann Thorac Surg 79 2005 1545 1550 (Pubitemid 40614563)
118. S. Kim, C. Foster, A. Lecchi, T.M. Quinton, D.M. Prosser, and J. Jin Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling Blood 99 2002 3629 3636 (Pubitemid 34534532)
119. S. Kim, J. Jin, and S.P. Kunapuli Relative contribution of G-protein-coupled pathways to protease-activated receptor-mediated Akt phosphorylation in platelets Blood 107 2006 947 954 (Pubitemid 43156291)
120. M. Kogushi, H. Kobayashi, T. Matsuoka, S. Suzuki, T. Kawahara, A. Kajiwara, and L. Hishinuma Anti-thrombotic and bleeding time effects of E5555, an orally active protease-activated receptor-1 antagonist, in guinea pigs. Abstract Circulation 108 2003
121. T. Komuro, S. Miwa, T. Minowa, Y. Okamoto, T. Enoki, and H. Ninomiya The involvement of a novel mechanism distinct from the thrombin receptor in the vasoconstriction induced by trypsin Br J Pharmacol 120 1997 851 856 (Pubitemid 27122725)
122. T. Kosoglou, and D.L. Cutler SCH 530348: rising-single-dose safety and tolerance study of SCH 530348 in healthy male volunteers (study report for protocol number P03449) 2005 Schering-Plough Research Institute Kenilworth
123. T. Kosoglou, L. Reyderman, R.G. Tiessen, A.A. van Vliet, R.R. Fales, R. Keller, B. Yang, and D.L. Cutler (PAR-1) antagonist SCH 530348 [abstract 245] Circulation 112 2005
124. R. Kranzhofer, S.K. Clinton, K. Ishii, S.R. Coughlin, J.W. Fenton 2nd, and P. Libby Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes Circ Res 79 1996 286 294 (Pubitemid 26255881)
125. K. Kristiansen Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function Pharmacol Ther 103 2004 21 80 (Pubitemid 38891912)
126. D.D. Ku, and J. Dai Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro J Cardiovasc Res 30 1997 649 657 (Pubitemid 27524506)
127. A. Kuliopulos, and L. Covic Blocking receptors on the inside: pepducin-based intervention of PAR signaling and thrombosis Life Sci 74 2003 255 262 (Pubitemid 37357056)
128. R.S. Lan, G.A. Stewart, and P.J. Henry Role of protease-activated receptors in airway function: a target for therapeutic intervention? Pharmacol Ther 95 2002 239 257 (Pubitemid 35247903)
129. F. Langer, C. Morys-Wortmann, B. Kusters, and J. Storck Endothelial protease-activated receptor-2 induces tissue factor expression and von Willebrand factor release Br J Haematol 105 1999 542 550 (Pubitemid 29232185)
130. A.J. Leger, S.L. Jacques, J. Badar, N.C. Kaneider, C.K. Derian, and P. Andrade-Gordon Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis Circulation 113 2006 1244 1254
131. R. Letienne, A. Leparq-Panissie, Y. Calmettes, F. Nadal-Wollbold, M. Perez, and B. Le Grand Antithrombotic activity of F 16618, a new PAR1 antagonist evaluated in extracorporeal arterio-venous shunt in the rat Biochem Pharmacol 79 2010 1616 1621
132. P. Libby The interface of atherosclerosis and thrombosis: basic mecahisms Vasc Med 3 1998 225 229 (Pubitemid 28553008)
133. L.-W. Liu, T.-K.H. Vu, C.T. Esmon, and S.R. Coughlin The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity J Biol Chem 266 1991 16977 16980 (Pubitemid 21907892)
134. P. Lova, F. Campus, R. Lombardi, M. Cattaneo, F. Sinigaglia, and C. Balduini Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin J Biol Chem 279 2004 25299 25306 (Pubitemid 38756783)
135. L.M. Luttrell, J. Ostrowski, S. Cotecchia, H. Kendall, and R.J. Lefkowitz Antagonism of catecholamine receptor signaling by expression of cytoplasmic domains of the receptors Science 259 1993 1453 1457 (Pubitemid 23101381)
136. L. Ma, R. Perini, W. McKnight, M. Dicay, A. Klein, and M.D. Hollenberg Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets Proc Natl Acad Sci U S A 102 2005 216 220 (Pubitemid 40094455)
137. H.I. Magazine, J.M. King, and K.D. Srivastava Protease activated receptors modulate aortic vascular tone Int J Cardiol 53 1996 S75 S80
138. A.B. Malik, and J.W.I. Fenton Thrombin-mediated increase in vascular endothelial permeability Semin Thromb Hemost 18 1992 193 199
139. B.E. Maryanoff, R.J. Santulli, D.F. McComsey, W.J. Hoekstra, K. Hoey, and C.E. Smith Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes Arch Biochem Biophys 386 2001 195 204 (Pubitemid 32989308)
140. B.E. Maryanoff, H.C. Zhang, P. Andrade-Gordon, and C.K. Derian Discovery of potent peptide-mimetic antagonists for the human thrombin receptor, protease-activated receptor-1 (PAR-1) Curr Med Chem Cardiovasc Hematol Agents 1 2003 13 36
141. T. Matsuoka, M. Kogushi, T. Kawata, A. Kimura, K. Chiba, and T. Musha Inhibitory effect of E5555, an orally active thrombin receptor antagonist, on initial hyperplasia following balloon injury. Abstract JACC 43 2004
142. D.F. McComsey, M.J. Hawkins, P. Andrade-Gordon, M.F. Addo, D. Oksenberg, and B.E. Maryanoff Heterocycle-peptide hybrid compounds. Aminotriazole- containing agonists of the thrombin receptor (PAR-1) Bioorg Med Chem Lett 9 1999 1423 1428 (Pubitemid 29232220)
143. C.A. McNamara, I.J. Sarembock, B.G. (*)Bachhuber, G.A. Stouffer, M. Ragosta, and W. Barry Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis Semin Thromb Hemost 22 1996 139 144 (Pubitemid 26239906)
144. C.A. McNamara, J.J. Sarembock, L.W. Gimple, J.W.I. Fenton, S.R. Coughlin, and G.R. Owens Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor J Clin Invest 91 1993 94 98 (Pubitemid 23037258)
145. A. McNicol, M. Sutherland, R. Zou, and J. Drouin Defective thrombin-induced calcium changes and aggregation of Bernard-Soulier platelets are not associated with deficient moderate-affinity receptors Arterioscler Thromb Vasc Biol 16 1996 628 632 (Pubitemid 26153106)
146. F.L. Minnear, M.A. DeMichele, S. Leonhardt, T.T. Andersen, and M. Teitler Isopreterenol antagonizes endothelial permeability induced by thrombin and thrombin receptor peptide J Appl Physiol 75 1993 1171 1179 (Pubitemid 23289606)
147. H. Mirza, V.A. Schmidt, C.K. Derian, J. Jesty, and W.F. Bahou Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell α- or β-tryptases Blood 90 1997 3914 3922 (Pubitemid 27484043)
148. H. Mirza, V. Yatsula, and W.F. Bahou The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells J Clin Invest 97 1996 1705 1714
149. J.D. Moffatt, and T.M. Cocks Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries Br J Pharmacol 125 1998 591 594 (Pubitemid 28482594)
150. M. Molino, D.F. Bainton, J.A. Hoxie, S.R. Coughlin, and L.F. Brass Thrombin receptors on human platelets: initial localisation and subsequent redistribution during platelet activation J Biol Chem 272 1997 6011 6017 (Pubitemid 27102440)
151. M. Molino, E.S. Barnathan, R. Numerof, J. Clark, M. Dreyer, and A. Cumashi Interactions of mast cell tryptase with thrombin receptors and PAR-2 J Biol Chem 272 1997 4043 4049 (Pubitemid 27078466)
152. M. Molino, P.N. Raghunath, A. Kuo, M. Ahuja, J.A. Hoxie, and L.F. Brass Differential expression of functional protease-activated receptor-2 (PAR-2) in human vascular smooth muscle cells Arterioscler Thromb Vasc Biol 18 1998 825 832 (Pubitemid 28267664)
153. M. Molino, M.J. Woolkalis, J. Reavey-Cantwell, D. Pratico, P. Andrade-Gordon, and E.S. Barnathan Endothelial cell thrombin receptors and PAR-2: two protease-activated receptors located in a single cellular environment J Biol Chem 272 1997 11133 11141 (Pubitemid 27184106)
154. D.A. Morrow, B.M. Scirica, K.A. Fox, G. Berman, J. Strony, and E. Veltri Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial Am Heart J 158 335-341 2009 e333
155. I. Muller, F. Besta, C. Schulz, S. Massberg, A. Schonig, and M. Gawaz Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement Thromb Haemost 89 2003 783 787 (Pubitemid 36603418)
156. I. Muramatsu, A. Laniyonu, G.J. Moore, and M.D. Hollenberg Vascular actions of thrombin receptor peptide Can J Physiol Pharmacol 70 1992 996 1003
157. T. Nagao, and P.M. Vanhoutte Hyperpolarization as a mechanism for endothelium-dependent relaxations in the porcine coronary artery J Physiol 445 1992 355 367
158. M. Nakanishi-Matsui, Y.W. Zheng, D.J. Sulciner, E.J. Weiss, M.J. Ludeman, and S.R. Coughlin PAR3 is a cofactor for PAR4 activation by thrombin Nature 404 2000 609 613 (Pubitemid 30205059)
159. T. Nanevicz, M. Ishii, L. Wang, M. Chen, J. Chen, and C.W. Turck Mechanisms of thrombin receptor agonist specificity. Chimeric receptors and complementary mutations identify an agonist recognition site J Biol Chem 270 1995 21619 21625
160. N.A. Nelken, S.J. Soifer, J. O'Keefe, T.K. Vu, I.F. Charo, and S.R. Coughlin Thrombin receptor expression in normal and atherosclerotic human arteries J Clin Invest 90 1992 1614 1621
161. J.R. Ngaiza, and E.A. Jaffe A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacyclin production in human endothelial cells Biochem Biophys Res Commun 179 1991 1656 1661
162. S. Nystedt, K. Emilsson, C. Wahlestedt, and J. Sundelin Molecular cloning of a potential proteinase activated receptor Proc Natl Acad Sci U S A 91 1994 9208 9212 (Pubitemid 24297883)
163. S. Nystedt, V. Ramakrishnan, and J. Sundelin The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells J Biol Chem 271 1996 14910 14915 (Pubitemid 26197572)
164. P.J. O'Brien, N. Prevost, M. Molino, M.K. Hollinger, M.J. Woolkalis, and D.S. Woulfe Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1 J Biol Chem 275 2000 13502 13509 (Pubitemid 30257415)
165. M.L. Ogletree, D.N. Harris, W.A. Schumacher, M.L. Webb, and R.N. Misra Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist J Pharmacol Exp Ther 264 1993 570 578 (Pubitemid 24283511)
166. T. Okamoto, Y. Murayama, Y. Hayashi, M. Inagaki, E. Ogata, and I. Nishimoto Identification of a Gs activator region of the beta 2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation Cell 67 1991 723 730 (Pubitemid 121001485)
167. R. Pape, B.H. Rauch, A.C. Rosenkranz, G. Kaber, and K. Schror Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells Arterioscler Thromb Vasc Biol 28 2008 534 540
168. C.Y. Peng, S.L. Pan, J.H. Guh, Y.N. Liu, Y.L. Chang, and S.C. Kuo The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injury Thromb Haemost 92 2004 1232 1239
169. M. Perez, M. Lamothe, C. Maraval, E. Mirabel, C. Loubat, and B. Planty Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo J Med Chem 52 2009 5826 5836
170. T.M. Quinton, S. Kim, C.K. Derian, J. Jin, and S.P. Kunapuli Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4 J Biol Chem 279 2004 18434 18439 (Pubitemid 38623260)
171. A. Rahman, K.N. Anwar, A.L. True, and A.B. Malik Thrombin-induced p65 homodimer binding to downstream NF-κB site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion J Immunol 162 1999 5466 5476 (Pubitemid 29307157)
172. B.H. Rauch, G.A. Scholz, D. Baumgartel-Allekotte, P. Censarek, J.W. Fischer, and A.A. Weber Cholesterol enhances thrombin-induced release of fibroblast growth factor-2 in human vascular smooth muscle cells Arterioscler Thromb Vasc Biol 27 2007 e20 e25
173. M. Riewald, and W. Ruf Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling J Biol Chem 280 2005 19808 19814 (Pubitemid 41379506)
174. J. Robin, R. Kharbanda, P.G. McLean, R. Campbell, and P. Vallance Protease-activated receptor 2-mediated vasodilatation in humans in vivo Circulation 107 2003 954 959
175. A.C. Rosenkranz, B.H. Rauch, K. Freidel, and K. Schror Regulation of protease-activated receptor-1 by vasodilatory prostaglandins via NFAT Cardiovasc Res 83 2009 778 784
176. F. Roviezzo, M. Bucci, V. Brancaleone, A. Di Lorenzo, P. Geppetti, and S. Farneti Proteinase-activated receptor-2 mediates arterial vasodilation in diabetes Arterioscler Thromb Vasc Biol 25 2005 2349 2354 (Pubitemid 41552653)
177. M. Saifeddine, B. Al-Ani, C.-H. Cheng, L. Wang, and M.D. Hollenberg Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue Br J Pharmacol 118 1996 521 530 (Pubitemid 26181846)
178. G.R. Sambrano, E.J. Weiss, Y.W. Zheng, W. Huang, and S.R. Coughlin Role of thrombin signalling in platelets in haemostasis and thrombosis Nature 413 2001 74 78 (Pubitemid 32843490)
179. R.M. Scarborough, M.A. Naughton, W. Teng, D.T. Hung, J. Rose, and T.K. Vu Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function J Biol Chem 267 1992 13146 13149
180. S.M. Seiler, and M.S. Bernatowicz Peptide-derived protease-activated receptor-1 (PAR-1) antagonists Curr Med Chem Cardiovasc Hematol Agents 1 2003 1 11
181. P. Sen, R. Gopalakrishnan, H. Kothari, S. Keshava, C.A. Clark, and C.T. Esmon Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protection Blood 117 2011 3199 3208
182. V.L. Serebruany, M. Kogushi, D. Dastros-Pitei, M. Flather, and D.L. Bhatt The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease Thromb Haemost 102 2009 111 119
183. M.J. Shapiro, E.J. Weiss, T.R. Faruqi, and S.R. Coughlin Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin J Biol Chem 275 2000 25216 25221
184. C.G. Sobey, J.D. Moffatt, and T.M. Cocks Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease-activated receptor-2 activation Stroke 30 1999 1933 1941 (Pubitemid 29411838)
185. U.J. Soh, M.R. Dores, B. Chen, and J. Trejo Signal transduction by protease-activated receptors Br J Pharmacol 160 2010 191 203
186. J.J. Stampfuss, K. Schror, and A.A. Weber Inhibition of platelet thromboxane receptor function by a thrombin receptor-targeted pepducin Nat Med 9 2003 1447 (author reply 1447-1448)
187. M. Steinhoff, N. Vergnolle, S.H. Young, M. Tognetto, S. Amadesi, and H.S. Ennes Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism Nat Med 6 2000 151 158 (Pubitemid 30082358)
188. A.A. Stoop, F. Lupu, and H. Pannekoek Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall Arterioscler Thromb Vasc Biol 20 2000 1143 1148
189. J. Storck, B. (*)Kusters, M. Vahland, C. Morys-Wortmann, and E.R. Zimmermann Trypsin induced von Willebrand factor release from human endothelial cells is mediated by PAR-2 activation Thromb Res 84 1996 363 473
190. J.L. Strande, A. Hsu, J. Su, X. Fu, G.J. Gross, and J.E. Baker SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts Basic Res Cardiol 102 2007 350 358 (Pubitemid 46909714)
191. T. Takeuchi, J.L. Harris, W. Huang, K.W. Yan, S.R. Coughlin, and C.S. Craik Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates J Biol Chem 275 2000 26333 26342
192. B. Tesfamariam Distinct receptors and signaling pathways in α-thrombin- and thrombin receptor peptide-induced vascular contractions Circ Res 74 1994 930 936 (Pubitemid 24121596)
193. B. Tesfamariam Thrombin receptor-mediated vascular relaxation differentiated by a receptor antagonist and desensitization Am J Physiol 267 1994 H1962 H1967
194. B. Tesfamariam, G.T. Allen, D. Normandin, and M.J. Antonaccio Involvement of the "tethered ligand" receptor in thrombin-induced endothelium-mediated relaxations Am J Physiol 265 1993 H1744 H1749
195. M. Thiyagarajan, J.A. Fernandez, S.M. Lane, J.H. Griffin, and B.V. Zlokovic Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1 J Neurosci 28 2008 12788 12797
196. H. Tomiyama, Y. Kimura, H. Mitsuhashi, T. Kinouchi, H. Yoshida, and T. Kushiro Relationship between endothelial function and fibrinolysis in early hypertension Hypertension 31 1998 321 327
197. TRACER Steering Committees The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale Am Heart J 158 327-334 2009 e324
198. E.R. Vandendries, J.R. Hamilton, S.R. Coughlin, B. Furie, and B.C. Furie Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis Proc Natl Acad Sci U S A 104 2007 288 292 (Pubitemid 46068024)
199. P.M. Vanhoutte, and C.M. Boulanger Endothelium-dependent responses in hypertension Hypertens Res 18 1995 87 98
200. N. Vergnolle, M.D. Hollenberg, K.A. Sharkey, and J.L. Wallace Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR-2)-activating peptides in the rat paw Br J Pharmacol 127 1999 1083 1091
201. 1) Br J Pharmacol 126 1999 1262 1268 (Pubitemid 29123764)
202. N. Vergnolle, W.K. Macnaughton, B. Al-Ani, M. Saifeddine, J.L. Wallace, and M.D. Hollenberg Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport Proc Natl Acad Sci U S A 95 1998 7766 7771 (Pubitemid 28293328)
203. P. Vidwan, A. Pathak, S. Sheth, J. Huang, D.M. Monroe, and G.A. Stouffer Activation of protease-activated receptors 3 and 4 accelerates tissue factor-induced thrombin generation on the surface of vascular smooth muscle cells Arterioscler Thromb Vasc Biol 30 2010 2587 2596
204. T.K. Vu, D.T. Hung, V.I. Wheaton, and S.R. Coughlin Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation Cell 64 1991 1057 1068 (Pubitemid 121001193)
205. E.J. Weiss, J.R. Hamilton, K.E. Lease, and S.R. Coughlin Protection against thrombosis in mice lacking PAR3 Blood 100 2002 3240 3244 (Pubitemid 35217073)
206. J.N. Wilcox, J. Rodriguez, R. Subramanian, J. Ollerensham, C. Zhong, and D.J. Hayzer Characterization of thrombin receptor expression during vascular lesion formation Circ Res 75 1994 1029 1038 (Pubitemid 24351448)
207. S. Wilson, B. Greer, J. Hooper, A. Zijlstra, B. Walker, and J. Quigley The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells Biochem J 388 2005 967 972 (Pubitemid 40941585)
208. C.C. Wu, S.W. Huang, T.L. Hwang, S.C. Kuo, F.Y. Lee, and C.M. Teng YD-3, a novel inhibitor of protease-induced platelet activation Br J Pharmacol 130 2000 1289 1296
209. C.C. Wu, T.L. Hwang, C.H. Liao, S.C. Kuo, F.Y. Lee, and C.Y. Lee Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3 Thromb Haemost 87 2002 1026 1033
210. C.C. Wu, T.L. Hwang, C.H. Liao, S.C. Kuo, F.Y. Lee, and C.M. Teng The role of PAR4 in thrombin-induced thromboxane production in human platelets Thromb Haemost 90 2003 299 308
211. W.-f. Xu, H. Andersen, T.E. Whitmore, S.R. Presnell, D.P. Yee, and A. Ching Cloning and characterization of human protease-activated receptor 4 Proc Natl Acad Sci 95 1998 6642 6646 (Pubitemid 28278033)
212. S.-G. Yang, A.A. Laniyonu, M. Saifeddine, G.J. Moore, and M.D. Hollenberg Actions of thrombin and thrombin receptor peptide analogues in gastric and aortic smooth muscle: development of bioassays for structure-activity studies Life Sci 51 1992 1325 1332
213. Z. Yang, F. Ruschitzka, T.J. Rabelink, G. Noll, F. Julmy, and H. Joch Different effects of thrombin receptor activation on endothelium and smooth muscle cells of human coronary bypass vessels. Implications for venous bypass graft failure Circulation 95 1997 1870 1876 (Pubitemid 27164405)
214. C.L. Yap, S.C. Hughan, S.L. Cranmer, W.S. Nesbitt, M.M. Rooney, and S. Giuliano Synergistic adhesive interactions and signaling mechanisms operating between platelet glycoprotein Ib/IX and integrin alpha IIbbeta 3. Studies in human platelets ans transfected Chinese hamster ovary cells J Biol Chem 275 2000 41377 41388 (Pubitemid 32054973)
215. H.C. Zhang, C.K. Derian, P. Andrade-Gordon, W.J. Hoekstra, D.F. McComsey, and K.B. White Discovery and optimization of a novel series of thrombin receptor (par-1) antagonists: potent, selective peptide mimetics based on indole and indazole templates J Med Chem 44 2001 1021 1024 (Pubitemid 32852127)
216. H.C. Zhang, K.B. White, H. Ye, D.F. McComsey, C.K. Derian, and M.F. Addo Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3 Bioorg Med Chem Lett 13 2003 3049 3053 (Pubitemid 36993634)